Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers.
Kooshkaki O, Derakhshani A, Safarpour H, Najafi S, Vahedi P, Brunetti O, Torabi M, Lotfinejad P, Paradiso AV, Racanelli V, Silvestris N, Baradaran B. Kooshkaki O, et al. Among authors: lotfinejad p. Int J Mol Sci. 2020 Jul 16;21(14):5034. doi: 10.3390/ijms21145034. Int J Mol Sci. 2020. PMID: 32708748 Free PMC article. Review.
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers.
Hosseinkhani N, Shadbad MA, Asghari Jafarabadi M, Karim Ahangar N, Asadzadeh Z, Mohammadi SM, Lotfinejad P, Alizadeh N, Brunetti O, Fasano R, Silvestris N, Baradaran B. Hosseinkhani N, et al. Among authors: lotfinejad p. Int J Mol Sci. 2021 Sep 27;22(19):10389. doi: 10.3390/ijms221910389. Int J Mol Sci. 2021. PMID: 34638729 Free PMC article.
PD-1/PD-L1 axis importance and tumor microenvironment immune cells.
Lotfinejad P, Kazemi T, Mokhtarzadeh A, Shanehbandi D, Jadidi Niaragh F, Safaei S, Asadi M, Baradaran B. Lotfinejad P, et al. Life Sci. 2020 Oct 15;259:118297. doi: 10.1016/j.lfs.2020.118297. Epub 2020 Aug 19. Life Sci. 2020. PMID: 32822718 Review.
PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines.
Lotfinejad P, Kazemi T, Safaei S, Amini M, Roshani Asl E, Baghbani E, Sandoghchian Shotorbani S, Jadidi Niaragh F, Derakhshani A, Abdoli Shadbad M, Silvestris N, Baradaran B. Lotfinejad P, et al. Biomed Pharmacother. 2021 Jun;138:111436. doi: 10.1016/j.biopha.2021.111436. Epub 2021 Mar 2. Biomed Pharmacother. 2021. PMID: 33667790 Free article.
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.
Shadbad MA, Safaei S, Brunetti O, Derakhshani A, Lotfinejad P, Mokhtarzadeh A, Hemmat N, Racanelli V, Solimando AG, Argentiero A, Silvestris N, Baradaran B. Shadbad MA, et al. Among authors: lotfinejad p. Genes (Basel). 2021 Aug 4;12(8):1206. doi: 10.3390/genes12081206. Genes (Basel). 2021. PMID: 34440380 Free PMC article.
Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systematic Review and Meta-Analysis Study.
Lotfinejad P, Asghari Jafarabadi M, Abdoli Shadbad M, Kazemi T, Pashazadeh F, Sandoghchian Shotorbani S, Jadidi Niaragh F, Baghbanzadeh A, Vahed N, Silvestris N, Baradaran B. Lotfinejad P, et al. Diagnostics (Basel). 2020 Sep 17;10(9):704. doi: 10.3390/diagnostics10090704. Diagnostics (Basel). 2020. PMID: 32957579 Free PMC article. Review.
A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead.
Abdoli Shadbad M, Hosseinkhani N, Asadzadeh Z, Derakhshani A, Karim Ahangar N, Hemmat N, Lotfinejad P, Brunetti O, Silvestris N, Baradaran B. Abdoli Shadbad M, et al. Among authors: lotfinejad p. Front Oncol. 2021 Aug 9;11:689839. doi: 10.3389/fonc.2021.689839. eCollection 2021. Front Oncol. 2021. PMID: 34434894 Free PMC article.
Antioxidants with two faces toward cancer.
Dastmalchi N, Baradaran B, Latifi-Navid S, Safaralizadeh R, Khojasteh SMB, Amini M, Roshani E, Lotfinejad P. Dastmalchi N, et al. Among authors: lotfinejad p. Life Sci. 2020 Oct 1;258:118186. doi: 10.1016/j.lfs.2020.118186. Epub 2020 Aug 6. Life Sci. 2020. PMID: 32768586 Review.
COVID-19 Infection: Concise Review Based on the Immunological Perspective.
Lotfinejad P, Asadzadeh Z, Najjary S, Somi MH, Hajiasgharzadeh K, Mokhtarzadeh A, Derakhshani A, Roshani E, Baradaran B. Lotfinejad P, et al. Immunol Invest. 2022 Feb;51(2):246-265. doi: 10.1080/08820139.2020.1825480. Epub 2020 Sep 28. Immunol Invest. 2022. PMID: 32981399 Review.
17 results